TREATMENT FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG NORMALIZES AIS LENGTH ABNORMALITY ALONG WITH HYPERACTIVITY IN PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)-DEFICIENT MICE.

Saved in:
Bibliographic Details
Title: TREATMENT FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG NORMALIZES AIS LENGTH ABNORMALITY ALONG WITH HYPERACTIVITY IN PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP)-DEFICIENT MICE.
Authors: Misaki Iwahashi, Takeshi Yoshimura, Wakana Harigai, Kazuhiro Takuma, Hitoshi Hashimoto, Taiichi Katayama, Atsuko Hayata-Takano
Source: The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2025 Supplement; Vol. 28.
Journal Info: Publisher: Oxford University Press / USA ISSN: 1461-1457
Database: MEDLINE Ultimate
Description
ISSN:1469-5111
DOI:10.1093/ijnp/pyae059.621